Bio-Thera and STADA have reached an exclusive commercialization and license agreement for BAT2506, a biosimilar candidate to Simponi® (golimumab) Bio-Thera will maintain responsibility for development, manufacturing, and supply of BAT2506 STADA will have exclusive rights to commercialize…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.